The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

AXSM FINANCIAL STATEMENTS

Axsome Therapeutics Inc — balance sheet, income statement and cash flow trends

AXSMAxsome Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
0500 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue776.6 M $Gross Profit724 M $ · 93%Operating Income-188.5 M $ · -24%Pre-tax Income-191.1 M $ · -25%Net Income to Owners-191.6 M $ · -25%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue776.6 M $+56.9%
Gross Profit724 M $+59.9%
Operating Income-188.5 M $—
EBITDA-179.8 M $—
Net Income to Owners-191.6 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0250 M500 M750 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets761.4 M
  • Equity83.3 M $11%
  • Current Liabilities460.4 M $60%
  • Long-term Liabilities217.7 M $29%

Key Figures

YoY change
Total Assets761.4 M $+19.0%
Total Liabilities678.1 M $+19.7%
Total Equity83.3 M $+14.0%
Cash & ST Investments319.9 M $+5.6%
Total Debt219.2 M $+0.9%
Net Debt-100.6 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-200 M-100 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-75 M-50 M-25 M0-71.3 M $Operating-700 K $Investing88.8 M $Financing16.8 M $Net Change

Key Figures

YoY change
Operating Cash Flow-71.3 M $—
Capital Expenditures371 K $-30.1%
Free Cash Flow-71.4 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on AXSM

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.